バイオバンクの世界市場

◆英語タイトル:Biobanking - Global Market Outlook (2016-2022)
◆商品コード:SMRC70523070
◆発行会社(リサーチ会社):Stratistics MRC
◆発行日:2017年3月
◆ページ数:166
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥460,650見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥582,750見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥832,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、バイオバンクの世界市場について調査・分析し、バイオバンクの世界市場規模、市場動向、関連企業分析などを含め、以下の構成でお届けいたします。
- エグゼクティブサマリー
- 序文
- バイオバンクの世界市場:市場動向分析
- バイオバンクの世界市場:競争要因分析
- バイオバンクの世界市場:用途別
・個体群のバイオバンク
・仮想バイオバンク
・組織のバイオバンク
- バイオバンクの世界市場:製品別
・消費財
・設備
- バイオバンクの世界市場:試料別
・幹細胞
・体液
・ヒト組織
・デオキシリボ核酸(DNA)
・リボ核酸(RNA)
・その他
- バイオバンクの世界市場:主要地域別分析
- バイオバンクの北米市場規模(アメリカ市場等)
- バイオバンクのヨーロッパ市場規模
- バイオバンクのアジア市場規模(日本市場、中国市場、インド市場等)
・バイオバンクの世界市場:主な市場開拓
- 関連企業分析
【レポートの概要】

According to Stratistics MRC, the Global Biobanking Market is expected to grow at a CAGR of 9.5% during the forecast period. Factors such as occurrence of chronic diseases, increase in aging population and decrease in research expenses are fueling the market growth. By sample type, human tissues segment is largest market accounting for almost 55% of the total market share during the forecast period. The unavailability of proper animal models for some neurological and psychiatric diseases is a significant factor in the growing preference for human tissue.

By product type, equipment segment commanded the largest market share during the forecast period. By geography, North America and Europe commanded the largest market share attendance of large players that are domiciled out of these nations.

Some of the key players in Biobanking market include Thermo Fisher Scientific, DNA Genotek, BioStorage Technologies, Askion GmBH, LVL Technologies, Cryo Bio System, BioRep SRL, Seralab, Tissue Solutions, SOL Group, Micronic, Brooks Life Science Systems, Fluidx, CryoXtract and Beckman Coulter.

Applications Covered:
• Population Biobanks
• Virtual Biobanks
• Tissue Biobanks

Product Types Covered:
• Consumables
• Equipment

Sample Types Covered:
• Stem Cells
• Bio-fluids
• Human Tissues
• Deoxyribonucleic acid (DNA)
• Ribonucleic acid (RNA)
• Other Sample Types

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Product Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Biobanking Market, By Application
5.1 Introduction
5.2 Population Biobanks
5.3 Virtual Biobanks
5.4 Tissue Biobanks

6 Global Biobanking Market, By Product Type
6.1 Introduction
6.2 Consumables
6.3 Equipment

7 Global Biobanking Market, By Sample Type
7.1 Introduction
7.2 Stem Cells
7.3 Bio-fluids
7.4 Human Tissues
7.5 Deoxyribonucleic acid (DNA)
7.6 Ribonucleic acid (RNA)
7.6 Other Sample Types

8 Global Biobanking Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Thermo Fisher Scientific
10.2 DNA Genotek
10.3 BioStorage Technologies
10.4 Askion GmBH
10.5 LVL Technologies
10.6 Cryo Bio System
10.7 BioRep SRL
10.8 Seralab
10.9 Tissue Solutions
10.10 SOL Group
10.11 Micronic
10.12 Brooks Life Science Systems
10.13 Fluidx
10.14 CryoXtract
10.15 Beckman Coulter

List of Tables
Table 1 Global Biobanking Market Outlook, By Region (2014-2022) ($MN)
Table 2 Global Biobanking Market Outlook, By Application (2014-2022) ($MN)
Table 3 Global Biobanking Market Outlook, By Population Biobanks (2014-2022) ($MN)
Table 4 Global Biobanking Market Outlook, By Virtual Biobanks (2014-2022) ($MN)
Table 5 Global Biobanking Market Outlook, By Tissue Biobanks (2014-2022) ($MN)
Table 6 Global Biobanking Market Outlook, By Product Type (2014-2022) ($MN)
Table 7 Global Biobanking Market Outlook, By Consumables (2014-2022) ($MN)
Table 8 Global Biobanking Market Outlook, By Equipment (2014-2022) ($MN)
Table 9 Global Biobanking Market Outlook, By Sample Type (2014-2022) ($MN)
Table 10 Global Biobanking Market Outlook, By Stem Cells (2014-2022) ($MN)
Table 11 Global Biobanking Market Outlook, By Bio-fluids (2014-2022) ($MN)
Table 12 Global Biobanking Market Outlook, By Human Tissues (2014-2022) ($MN)
Table 13 Global Biobanking Market Outlook, By Deoxyribonucleic acid (DNA) (2014-2022) ($MN)
Table 14 Global Biobanking Market Outlook, By Ribonucleic acid (RNA) (2014-2022) ($MN)
Table 15 Global Biobanking Market Outlook, By Other Sample Types (2014-2022) ($MN)
Table 16 North America Biobanking Market Outlook, By Country (2014-2022) ($MN)
Table 17 North America Biobanking Market Outlook, By Application (2014-2022) ($MN)
Table 18 North America Biobanking Market Outlook, By Population Biobanks (2014-2022) ($MN)
Table 19 North America Biobanking Market Outlook, By Virtual Biobanks (2014-2022) ($MN)
Table 20 North America Biobanking Market Outlook, By Tissue Biobanks (2014-2022) ($MN)
Table 21 North America Biobanking Market Outlook, By Product Type (2014-2022) ($MN)
Table 22 North America Biobanking Market Outlook, By Consumables (2014-2022) ($MN)
Table 23 North America Biobanking Market Outlook, By Equipment (2014-2022) ($MN)
Table 24 North America Biobanking Market Outlook, By Sample Type (2014-2022) ($MN)
Table 25 North America Biobanking Market Outlook, By Stem Cells (2014-2022) ($MN)
Table 26 North America Biobanking Market Outlook, By Bio-fluids (2014-2022) ($MN)
Table 27 North America Biobanking Market Outlook, By Human Tissues (2014-2022) ($MN)
Table 28 North America Biobanking Market Outlook, By Deoxyribonucleic acid (DNA) (2014-2022) ($MN)
Table 29 North America Biobanking Market Outlook, By Ribonucleic acid (RNA) (2014-2022) ($MN)
Table 30 North America Biobanking Market Outlook, By Other Sample Types (2014-2022) ($MN)
Table 31 Europe Biobanking Market Outlook, By Country (2014-2022) ($MN)
Table 32 Europe Biobanking Market Outlook, By Application (2014-2022) ($MN)
Table 33 Europe Biobanking Market Outlook, By Population Biobanks (2014-2022) ($MN)
Table 34 Europe Biobanking Market Outlook, By Virtual Biobanks (2014-2022) ($MN)
Table 35 Europe Biobanking Market Outlook, By Tissue Biobanks (2014-2022) ($MN)
Table 36 Europe Biobanking Market Outlook, By Product Type (2014-2022) ($MN)
Table 37 Europe Biobanking Market Outlook, By Consumables (2014-2022) ($MN)
Table 38 Europe Biobanking Market Outlook, By Equipment (2014-2022) ($MN)
Table 39 Europe Biobanking Market Outlook, By Sample Type (2014-2022) ($MN)
Table 40 Europe Biobanking Market Outlook, By Stem Cells (2014-2022) ($MN)
Table 41 Europe Biobanking Market Outlook, By Bio-fluids (2014-2022) ($MN)
Table 42 Europe Biobanking Market Outlook, By Human Tissues (2014-2022) ($MN)
Table 43 Europe Biobanking Market Outlook, By Deoxyribonucleic acid (DNA) (2014-2022) ($MN)
Table 44 Europe Biobanking Market Outlook, By Ribonucleic acid (RNA) (2014-2022) ($MN)
Table 45 Europe Biobanking Market Outlook, By Other Sample Types (2014-2022) ($MN)
Table 46 Asia Pacific Biobanking Market Outlook, By Country (2014-2022) ($MN)
Table 47 Asia Pacific Biobanking Market Outlook, By Application (2014-2022) ($MN)
Table 48 Asia Pacific Biobanking Market Outlook, By Population Biobanks (2014-2022) ($MN)
Table 49 Asia Pacific Biobanking Market Outlook, By Virtual Biobanks (2014-2022) ($MN)
Table 50 Asia Pacific Biobanking Market Outlook, By Tissue Biobanks (2014-2022) ($MN)
Table 51 Asia Pacific Biobanking Market Outlook, By Product Type (2014-2022) ($MN)
Table 52 Asia Pacific Biobanking Market Outlook, By Consumables (2014-2022) ($MN)
Table 53 Asia Pacific Biobanking Market Outlook, By Equipment (2014-2022) ($MN)
Table 54 Asia Pacific Biobanking Market Outlook, By Sample Type (2014-2022) ($MN)
Table 55 Asia Pacific Biobanking Market Outlook, By Stem Cells (2014-2022) ($MN)
Table 56 Asia Pacific Biobanking Market Outlook, By Bio-fluids (2014-2022) ($MN)
Table 57 Asia Pacific Biobanking Market Outlook, By Human Tissues (2014-2022) ($MN)
Table 58 Asia Pacific Biobanking Market Outlook, By Deoxyribonucleic acid (DNA) (2014-2022) ($MN)
Table 59 Asia Pacific Biobanking Market Outlook, By Ribonucleic acid (RNA) (2014-2022) ($MN)
Table 60 Asia Pacific Biobanking Market Outlook, By Other Sample Types (2014-2022) ($MN)
Table 61 Rest of the World Biobanking Market Outlook, By Country (2014-2022) ($MN)
Table 62 Rest of the World Biobanking Market Outlook, By Application (2014-2022) ($MN)
Table 63 Rest of the World Biobanking Market Outlook, By Population Biobanks (2014-2022) ($MN)
Table 64 Rest of the World Biobanking Market Outlook, By Virtual Biobanks (2014-2022) ($MN)
Table 65 Rest of the World Biobanking Market Outlook, By Tissue Biobanks (2014-2022) ($MN)
Table 66 Rest of the World Biobanking Market Outlook, By Product Type (2014-2022) ($MN)
Table 67 Rest of the World Biobanking Market Outlook, By Consumables (2014-2022) ($MN)
Table 68 Rest of the World Biobanking Market Outlook, By Equipment (2014-2022) ($MN)
Table 69 Rest of the World Biobanking Market Outlook, By Sample Type (2014-2022) ($MN)
Table 70 Rest of the World Biobanking Market Outlook, By Stem Cells (2014-2022) ($MN)
Table 71 Rest of the World Biobanking Market Outlook, By Bio-fluids (2014-2022) ($MN)
Table 72 Rest of the World Biobanking Market Outlook, By Human Tissues (2014-2022) ($MN)
Table 73 Rest of the World Biobanking Market Outlook, By Deoxyribonucleic acid (DNA) (2014-2022) ($MN)
Table 74 Rest of the World Biobanking Market Outlook, By Ribonucleic acid (RNA) (2014-2022) ($MN)
Table 75 Rest of the World Biobanking Market Outlook, By Other Sample Types (2014-2022) ($MN)



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ バイオバンクの世界市場(Biobanking - Global Market Outlook (2016-2022) )]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆